US Patent Issued to Amgen on Sept. 30 for "Formulations of apremilast" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,136, issued on Sept. 30, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Formulations of apremilast" was invented by William Brett Caldwell (Thousand Oaks, Calif.), Nathan Bennette (Thousand Oaks, Calif.), Christi Hostetler (Thousand Oaks, Calif.), Kazden Ingram (Thousand Oaks, Calif.), Dory King (Thousand Oaks, Calif.), Kyle Kyburz (Thousand Oaks, Calif.) and Alison Viles (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are oral dosage forms comprising a) a core tablet comprising (i) a drug layer comprising apremilast and hypromellose acetate succinate (HPMCAS) in an amorphous solid dispersion; and (ii) a ...